Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme detoxification protein (PfHDP) is an enzyme in Plasmodium falciparum essential for the detoxification of heme released during hemoglobin digestion within infected erythrocytes. Free heme is highly toxic due to its pro-oxidant activity; the parasite converts it to insoluble, non-toxic hemozoin via the activity of PfHDP and potentially other accessory proteins and lipids. HDP is one of the most potent enzymes for this conversion and is functionally conserved across the Plasmodium genus. PfHDP, localized mainly in the food vacuole, binds heme molecules and catalyzes their dimerization and crystallization into hemozoin. The formation of hemozoin is the target of most quinoline antimalarials, making PfHDP and other heme detoxification pathway proteins attractive drug targets for antimalarial therapy[1][4][5]. Drug resistance and redundancy in the heme detoxification pathway are therapeutic challenges, and direct drug inhibitors of PfHDP are under investigation.
Inhibition of heme polymerization or crystallization to hemozoin, leading to toxic heme accumulation and parasite death[5][6].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification protein (Plasmodium falciparum) (PfHDP).